Tetiana Harashchenko

Tetiana Harashchenko

Auto-generated profile, based on publicly available information

Tetiana Harashchenko

ДУ «Всеукраїнський центр материнства та дитинства НАМН України», м. Київ

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2023 in CHILD`S HEALTH
Verified
Journal Article
Open access
PDF file
YAYu.G. Antypkin
Yu.G. Antypkin
VLV.F. Lapshyn
V.F. Lapshyn
TUT.R. Umanets
T.R. Umanets
TKT.M. Kaminska
T.M. Kaminska
NBN.V. Banadyha
N.V. Banadyha
VPVl.V. Podolskiy
Vl.V. Podolskiy
Background. Studying COVID-19 prevalence among children is important for constant monitoring of the epidemiological situation, determination of the most vulnerable categories of children, and planning preventive measures. The aim of our research was a retrospective study of COVID-19 prevalence among children of Ukraine in 2020. Materials and methods. A retrospective study of COVID-19 prevalence among children from different regions of Ukraine was conducted, based on official statistical reports of the Ministry of Health of Ukraine. The prevalence of COVID-19 was measured as the number of cases per 100,000 children. Results. Among the population of Ukraine, children with confirmed SARS-CoV-2 infection amounted to 0.12 %, and among the children’s population of Ukraine — 0.7 %, while the prevalence rate reached 688.64. The incidence of COVID-19 among children in 2020 was highest in Kyiv, Chernivtsi, and Zaporizhzhia regions, and the lowest one was recorded in Kirovohrad, Luhansk, and Donetsk regions. In the age structure of Ukrainian children with SARS-CoV-2 infection, adolescents (63.8 %) prevailed. Conclusions. Adolescents were the age group of children most vulnerable to SARS-CoV-2 in Ukraine. The relatively low COVID-19 prevalence among children in Ukraine may be evidence of underdiagnosis due to insufficient coverage of laboratory testing for SARS-CoV-2 infection in the first year of the pandemic.

7 August 2023
Verified
Journal Article
Open access
THTetiana Harashchenko
Tetiana Harashchenko
TUTetiana Umanets
Tetiana Umanets
VPVolodymyr Podolskiy
Volodymyr Podolskiy
TKTetiana Kaminska
Tetiana Kaminska
YMYuriy Marushko
Yuriy Marushko
YAYurii Antypkin
Yurii Antypkin
In December 2019, the Chinese city of Wuhan reported the first cases of pneumonia from a new type of beta coronavirus named SARS-CoV-2. In the early days of the COVID-19 outbreak, paediatric patients were thought to be immune to the new virus; however, further studies have shown people of all ages to be susceptible to the virus. Identify and describe the clinical and epidemiological features of COVID-19 among hospitalized children in Ukraine. Retrospective study of 171 children aged 2 months to 18 years who were hospitalized with laboratory-confirmed SARS-CoV-2. Most patients in the study had a moderate progression of the disease (77.78%, or n=133), whereas a severe course was noted in 22.22% (n=38). Across age groups, children aged 6-12 was the predominant age group affected (35.67%, or n=61). The most common symptoms were fever in 88.2% of patients, sore throat in 69.2% and cough in 60.9%. Symptoms associated with dyspnoea and cyanosis were significantly more common in children with the severe course (p<0.05). Almost half of children had at least one comorbidity, the most prevalent being chronic tonsillitis (11.8% of patients) and anemia (6.5% of patients). A positive correlation (r=0.7 p<0.05) was found between CRP levels and COVID-19 severity. X-ray changes in the lungs were present in 76.61% of examined children and ground-glass opacity symptom was registered in 50.88%. COVID-19 among hospitalized children in Ukraine usually has a moderate course of illness and a good prognosis.

9 September 2023 in European Respiratory Journal
Verified
Conference Paper
Closed access
THTetiana Harashchenko
Tetiana Harashchenko
TUTetiana Umanets
Tetiana Umanets
VLVolodymyr Lapshyn
Volodymyr Lapshyn
TKTetiana Kaminska
Tetiana Kaminska
LLLudmila Livshits
Ludmila Livshits
YAYuriy Antipkin
Yuriy Antipkin
Background: COVID-19 caused by SARS-CoV-2 remains a major public health problem. Previous studies demonstrated that interferon lambda 4 (IFNL4) has antiviral activity against viral infections of the upper respiratory tract, including some coronaviruses. However, we have limited data about the association of these genetic variants with SARS-CoV-2 infection, especially among children with recurrent respiratory infections (RRI). Objectives: The aim of this study was to identify a relationship between the ss469415590 polymorphism of gene IFNL4 and the severity of COVID-19. Materials and methods: The study included 70 children with RRI, after laboratory-confirmed COVID-19. Patients were genotyped for IFNL4 ss469415590 and split the patients among two groups. Group 1 – 28.6% (n=20) children with moderate COVID-19, group 2 – 71.4% (n=30) with severe course of the disease. Results: The presence of the CC allele of ss469415590 was significantly lower in group 2 compared to group 1 (38.6% vs 48.6%, p0.05); OR=0.3 (CI 0.086-1). Conclusions: Our study confirmed the association between the CC allele of ss469415590 and the course of COVID-19 among children with RRI, suggesting an important potential protective role for this genetic variant of IFNL4 in the prevention and prognosis of the disease.

15 June 2025 in Modern pediatrics. Ukraine
Verified
Journal Article
Open access
PDF file
KUKyiv Si Ukrainian Center Of Maternity And Childhood Of The Nams Of Ukraine
Kyiv Si Ukrainian Center Of Maternity And Childhood Of The Nams Of Ukraine
TUT.R. Umanets
T.R. Umanets
VDV.O. Dzisiak
V.O. Dzisiak
ABA.A. Buratynska
A.A. Buratynska
THT.A. Harashchenko
T.A. Harashchenko
YBYu.M. Bondarenko
Yu.M. Bondarenko
The integrity of the respiratory epithelium protects the airways from the penetration of external harmful agents. Impairments in the structure and function of the epithelial barrier can lead to chronic inflammatory processes that underlie the pathogenesis of numerous allergic and inflammatory respiratory diseases, particularly in children. Аim - to review contemporary scientific literature on the role of epithelial barrier dysfunction in the development of allergic diseases, and to examine methods for the diagnosis and treatment of respiratory epithelial dysfunction (RED) based on the latest scientific evidence. An analysis of literature from international databases, including PubMed, ScienceDirect, and Google Scholar, for the period 2018-2025 was conducted. RED involves the disruption of its structural integrity, leading to a compromised barrier function and increased permeability to external agents such as allergens, pollutants, and pathogens. In patients with asthma, a decreased expression of proteins that form tight junctions between epithelial cells is observed, constituting a critical pathogenetic mechanism in the development of respiratory allergic diseases. The combined use of modern methods—such as histological and immunohistochemical analyses, electron microscopy, mass spectrometry, proteomics, and the study of alarmins — allows for a more effective assessment of the respiratory epithelial barrier's status. Modern therapeutic strategies for RED are aimed at restoring the structure and function of epithelial tight junctions. Conclusions. RED is a key factor in the development of asthma and other respiratory diseases, especially in the pediatric population. Early diagnosis and timely intervention to enhance epithelial barrier function are critical for achieving successful disease control. Future research prospects include the development of novel preventive and therapeutic approaches aimed at restoring and maintaining the integrity of the respiratory epithelium. The authors declare no conflict of interest.

30 September 2022 in Modern pediatrics. Ukraine
Verified
Journal Article
Closed access
YAYu.G. Antipkin
Yu.G. Antipkin
VLV.F. Lapshyn
V.F. Lapshyn
TUT.R. Umanets
T.R. Umanets
TKT.M. Kaminska
T.M. Kaminska
YMYu.V. Marushko
Yu.V. Marushko
LLLudmila Livshits
Ludmila Livshits
Purpose - to study the features of vitamin D status and the effect of vitamin D3 supplementation on 25(OH)D in the serum of school-age children with COVID-19, taking into account the genotype of the rs2228570 polymorphism of the vitamin D receptor (VDR) gene. Materials and methods. The pilot, prospective, open-label study included 36 schoolchildren aged 9-16 who experienced asymptomatic (12 children) and mild / moderate (24 children) COVID-19. In all children were studied the content of 25(OH)D in blood serum and its dynamics under the influence of supplementation of 1000 IU per day for 12 weeks, taking into account the genotypes and frequency of distribution of alleles of the rs2228570 polymorphism of the VDR gene (26 children). Results. Children with asymptomatic COVID-19 were characterized by normal values of 25(OH)D (32.682.12 ng/ml). Children who underwent mild / moderate COVID-19 were probably more (41.7%) likely to have a state of hypovitaminosis vitamin D (27.362.12 ng/ml) and fewer children (58.3%) with an optimal level of 25(OH)D than children with asymptomatic disease. In 80.7% of the examined children, the genotype was determined by the rs2228570 polymorphism of the VDR gene, which includes the G allele with greater transcriptional activity of the VDR receptor. Supplementation of 1000 IU of cholecalciferol per day, regardless of 25(OH)D status and genotype for this polymorphism probably increased the supply of vitamin D in examined children with a tendency to increase 25(OH)D in children with genotype by polymorphism rs2228570 VDR gene, which includes allele G. Conclusions. Vitamin D deficiency can be considered as a risk factor for the symptomatic course of COVID-19 in children, which requires monitoring and correction of vitamin D status, the effectiveness of which can be determined by the genotype of the rs2228570 polymorphism of the VDR gene. Further studies of the role of vitamin D / VDR complex in the development and severity of COVID-19 in children will significantly expand the understanding of the pathogenetic relationship, to suggest and predict the effectiveness of personalized vitamin D supplementation regimens. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.

9 December 2024 in Paediatrica Indonesiana
Verified
Journal Article
Open access
PDF file
THTetiana Harashchenko
Tetiana Harashchenko
TUTetiana Umanets
Tetiana Umanets
TKTetiana Kaminska
Tetiana Kaminska
LVLapshyn Volodymyr
Lapshyn Volodymyr
YAYurii Antypkin
Yurii Antypkin
Background The SARS-CoV-2 virus, the causative agent of the coronavirus disease (COVID-19), mutated during its replication and spread among the population. These mutations led to new viral variants, which differed in their characteristics and manifestations, contributing to the wave-like progression of the COVID-19. The Centers for Disease Control and Prevention classified variants based on the public health risk include variants of interest such as ? and ?, variants of concern including ?, ?, ?, ?, ?, variants of high consequence, and variants being monitored. Objective To conduct a comparative analysis of the demographic, clinical, epidemiological, radiological, and laboratory characteristics of hospitalized children with COVID-19 during different waves of the disease. Methods A cohort study was conducted involved 337 children aged one month to 18 years who were hospitalized with laboratory-confirmed COVID-19 between 2020 and 2023 in Ukraine. Results During wave 3 (W3), wave 5 (W5) and wave 6 (W6), children under 3 years of age were hospitalized more frequently. The severe course of disease predominantly occurred during W3 period, with 47.3% cases demonstrating severe symptoms such as respiratory failure, bilateral pneumonia, and significant changes in laboratory parameters, including white blood cell count, erythrocyte sedimentation rate, D-dimer, and procalcitonin. One fatal case was reported during W3. The duration of hospitalization was longest for children in the W3 group. A moderate course of the disease was significantly more prevalent among hospitalized children in the first wave (77.78%, P<0.05), characterized by interstitial changes in the lungs, elevated C-reactive protein, and platelet levels. Fever and intoxication syndrome were reported with similar frequency during all waves of COVID-19. Conclusion Our study demonstrates the dynamic changes in manifestations and the progression of the disease across different variants of concern of SARS-CoV-2. The most severe cases of COVID-19 was observed during the third wave which predominated by the ? (Delta) strain.